Matthew Sherman
Direttore Tecnico/Scientifico/R&S presso DECIPHERA PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Teofilo Raad | M | 54 |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | 7 anni |
| Thomas Bures | M | 49 | 7 anni | |
| Steven Hoerter | M | 53 | 6 anni | |
| Richard Batycky | M | 56 |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | 17 anni |
| James Bristol | M | 77 | 17 anni | |
| Stephen Yoder | M | 48 | 14 anni | |
| Ron Squarer | M | 57 | 5 anni | |
| James Geraghty | M | 69 | 7 anni | |
| Edward Benz | M | 78 |
Harvard Medical School
| 22 anni |
| Maya Said | M | 47 | 5 anni | |
| Tucker Kelly | M | 53 | 9 anni | |
| Jama Pitman | M | 45 | 9 anni | |
| Rajesh Devraj | M | - | 13 anni | |
| Dennis Walsh | M | 56 | 9 anni | |
| Peter Kiener | M | 72 | 6 anni | |
| Patricia Allen | F | 62 | 8 anni | |
| John Martin | M | 63 | 9 anni | |
| Franklin Friedman | M | 66 | 5 anni | |
| Michael Richman | M | 63 | 10 anni | |
| Christopher Kiritsy | M | 59 | 8 anni | |
| Susan Kelley | M | 69 | 5 anni | |
| Norman Payson | M | 49 |
Geisel School of Medicine
| - |
| Ann J. Barbier | M | 59 | 6 anni | |
| Fabiola Cobarrubias | M | 57 |
Geisel School of Medicine
| - |
| Nezam Afdhal | M | 67 |
Harvard Medical School
| 24 anni |
| David H. Sachs | M | 77 |
Harvard Medical School
| 33 anni |
| Michael C. Gibson | M | - |
Harvard Medical School
| 37 anni |
| Michael J. McKenna | M | 67 |
Harvard Medical School
| 28 anni |
| Dashyant Dhanak | M | 63 | 1 anni | |
| Hitto Kaufmann | M | 53 | 5 anni | |
| Shane Olwill | M | 48 | 13 anni | |
| Rodrigo Ruiz Soto | M | - | 7 anni | |
| Kayti Aviano | F | - | 7 anni | |
| Kelley Dealhoy | F | - | 2 anni | |
| Lisa Amaya Price | F | - | 2 anni | |
| Peter Libby | M | 77 |
Harvard Medical School
| 28 anni |
| Spyridon Artavanis-Tsakonas | M | 77 |
Harvard Medical School
| 25 anni |
| Daniel Martin | M | 49 | 6 anni | |
| Gregory Verdine | M | 65 |
Harvard Medical School
| 35 anni |
| Thomas Scully | M | 67 |
Geisel School of Medicine
| - |
| Barbara McNeil | M | 83 |
Harvard Medical School
| 41 anni |
| Jerome Groopman | M | 72 |
Harvard Medical School
| 32 anni |
| Dennis Selkoe | M | 80 |
Harvard Medical School
| 24 anni |
| John Halamka | M | 61 |
Harvard Medical School
| 28 anni |
| Lan Bo Chen | M | 80 |
Harvard Medical School
| 27 anni |
| George Demetri | M | 67 |
Harvard Medical School
| 36 anni |
| James J. Mongan | M | 82 |
Harvard Medical School
| 28 anni |
| Richard Mulligan | M | 69 |
Harvard Medical School
| 28 anni |
| Christine Seidman | M | 71 |
Harvard Medical School
| 27 anni |
| Thomas F. Deuel | M | 89 |
Harvard Medical School
| 26 anni |
| Amit Munshi | M | 56 |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | - |
| George Church | M | 69 |
Harvard Medical School
| 38 anni |
| Mark Iwicki | M | 57 |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | - |
| Jean-Pierre Kinet | M | 70 |
Harvard Medical School
| 29 anni |
| Rakesh Kumar Jain | M | 74 |
Harvard Medical School
| 33 anni |
| Jeff Held | M | 55 | 6 anni | |
| Barry S. Fogel | M | - |
Harvard Medical School
| 25 anni |
| Kevin Brodbeck | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Glenn Batchelder | M | 63 | 3 anni | |
| Nicholas N. Vahanian | M | 56 | 20 anni | |
| Daniel Flynn | M | 70 | 20 anni | |
| John L. Knopf | M | 71 | 13 anni | |
| Richard Hawkins | M | 75 | - | |
| Terry McGuire | M | 68 | 14 anni | |
| Robert Clarke | M | 56 | 15 anni | |
| Charles Link | M | 64 | 20 anni | |
| Habib Dable | M | 54 | 5 anni | |
| John Quisel | M | 53 | 14 anni | |
| Michael Taylor | M | 69 | 7 anni | |
| Allan Reine | M | 49 | 2 anni | |
| William Duke | M | 51 | 4 anni | |
| Adam Veness | M | 38 | 7 anni | |
| Francois Nader | M | 67 | 7 anni | |
| John Henneman | M | 62 | 4 anni | |
| Keith S. Ehrlich | M | 73 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 10 anni |
| Kevin McLaughlin | M | 67 | 11 anni | |
| Ahmed Mousa | M | 40 | 7 anni | |
| Lishan Aklog | M | 58 |
Harvard Medical School
| 8 anni |
| Karen Smith | M | 56 | 4 anni | |
| Christopher Rovaldi | M | 50 | 11 anni | |
| Douglas Pagán | M | 52 | 6 anni | |
| Paolo Pucci | M | 63 | 3 anni | |
| Jean Bizzari | M | 69 | 5 anni | |
| Ernie Talarico | M | 53 | 21 anni | |
| Ed Kania | M | 66 | 11 anni | |
| Thomas McCourt | M | 66 | 5 anni | |
| Wylie W. Vale | M | 82 | 9 anni | |
| Paul Edick | M | 67 | 7 anni | |
| Anthony Evnin | M | 83 | 10 anni | |
| George Golumbeski | M | 67 | 7 anni | |
| Todd James | M | - | 6 anni | |
| Steven D. Ertel | M | 54 | 11 anni | |
| Terrence Kearney | M | 69 | 7 anni | |
| Michael Ross | M | 75 | 4 anni | |
| Eric W. Jacobson | M | 66 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 4 anni |
| Joseph Zakrzewski | M | 60 | 10 anni | |
| Steven Prelack | M | 66 | 5 anni | |
| Jasbir Seehra | M | 68 | 6 anni | |
| Christoph H. Westphal | M | 56 | 10 anni | |
| William Reardon | M | 78 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 12 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 97 | 97.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Matthew Sherman
- Contatti personali
